Niti Carlson, MD
Gynecology · Evans, GANPI 1972599363
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,557 of the $8,199 with a category attached, or 80.0%. It is spread thinly across 35 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $2,405 and has fallen 54.3% since, to $1,099 in 2025. Among gynecology clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 431 payments — averaging $19.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- Applied Medical Resources Corporation$1K
- Astellas Pharma US Inc$749
- Sumitomo Pharma America, Inc.$494
- AbbVie$424
- Pfizer$346
- plus $3K from 29 others
What the payments were for
- Travel & lodging$1,27015%
- Food & beverage$6,55780%
- Education$3715%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 127 | $1,722 |
| Applied Medical Resources Corporation | 3 | $1,350 |
| Astellas Pharma US Inc | 39 | $749 |
| Sumitomo Pharma America, Inc. | 29 | $494 |
| AbbVie(2 entities) | 26 | $424 |
| Pfizer | 22 | $346 |
| Merz North America, Inc. | 6 | $344 |
| Currax Pharmaceuticals LLC | 31 | $325 |
| Mayne Pharma Commercial LLC | 15 | $239 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $233 |
| Millicent US Inc | 13 | $220 |
| Bayer | 10 | $150 |
| Urovant Sciences Inc | 9 | $146 |
| Exact Sciences | 8 | $125 |
| Therapeuticsmd, Inc. | 7 | $122 |
| Duchesnay USA Incorporated | 8 | $119 |
| Amgen | 7 | $101 |
| Lilly USA, LLC | 6 | $97 |
| Avion Pharmaceuticals | 7 | $87 |
| AMAG Pharmaceuticals, Inc. | 5 | $87 |
| Johnson & Johnson | 1 | $76 |
| Hologic Sales And Service, LLC | 4 | $76 |
| Agile Therapeutics, Inc. | 4 | $67 |
| GSK | 4 | $60 |
| Shield Therapeutics Inc | 3 | $53 |
| Organon | 2 | $46 |
| Evofem Biosciences, Inc. | 2 | $46 |
| Exeltis, USA Inc. | 3 | $45 |
| Coopersurgical, Inc. | 2 | $43 |
| Boston Scientific | 2 | $43 |
| Axonics, Inc. | 2 | $42 |
| Intuitive Surgical | 2 | $38 |
| Myovant Sciences Inc. | 2 | $32 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $31 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GelPOINT V-Path$1,270
- XEOMIN$126
- Saxenda$125
- Wegovy$121
- ANNOVERA$121
How this compares
$8,199 in reported general payments places this provider in the 90th percentile of 119 gynecology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 29 | $29,829 |
| Estradiol | 100 | $5,141 |
| Solifenacin Succinate | 16 | $934 |
| Oxybutynin Chloride ErOxybutynin Chloride | 25 | $717 |
| ValacyclovirValacyclovir Hcl | 11 | $292 |
| Terconazole | 12 | $281 |
| Alendronate Sodium | 28 | $201 |
| Gabapentin | 26 | $148 |
| Fluoxetine Hcl | 16 | $96 |
| Zolpidem Tartrate | 12 | $71 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $494 | $29,82929 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 119 gynecology providers in Georgia.
Other gynecology in Evans
- Soyini HawkinsPeachtree Corners$585K
- Rama RaoAtlanta$343K
- Michael RandellAtlanta$196K
- Ceana NezhatAtlanta$157K
- Sujatha ReddyAtlanta$116K
- Thomas LyonsConyers$71K
- Jennifer ElliottAlpharetta$55K
- Daniel EstevesLawrenceville$16K
- Nathan MordelRoswell$15K
- Michael BakarichLagrange$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.